Close Menu

NYGC: Mary-Claire King

Mary-Claire King has joined the New York Genome Center faculty on a consulting basis as a senior associate core member. She is the American Cancer Society Professor in the Department of Genome Sciences and Medicine at the University of Washington in Seattle. At the NYGC, she will work closely with Thomas Lehner, the center's recently appointed scientific director of neuropsychiatric disease, and act as a senior adviser to both Lehner and Tom Maniatis, the center's CEO.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.